They are a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases
Last Closing Price
February 8, 2018
To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277